The assessment of side effects of tyrosine kinase inhibitors (TKI) applied in patients with advanced thyroid cancer (TC) - one centre experience

被引：0
|
作者：
Jolanta Krajewska
Aleksandra Kukulska
Ewa Paliczka-Cieślik
Daria Handkiewicz-Junak
Tomasz Gawlik
Tomasz Olczyk
Aleksandra Kropińska
Aleksander Skoczylas
Barbara Michalik
Barbara Jarząb
机构：
[1] M. Sklodowska-Curie Memorial Cancer Centre and Institute of Oncology,
[2] Gliwice Branch,undefined
来源：
Thyroid Research | / 6卷 / Suppl 2期
关键词：
Meningitis; Thyroid Cancer; Tyrosine Kinase Inhibitor; Lymphopenia; Prospective Clinical Trial;
D O I：
10.1186/1756-6614-6-S2-A33
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Tyrosine kinase inhibitors in patients with advanced anaplastic thyroid cancer: an effective analysis based on real-world retrospective studies
    Kuang, Bo-Hua
    Zhang, Wen-Xuan
    Lin, Guo-He
    Fu, Chen
    Cao, Ru-Bo
    Wang, Bi-Cheng
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [32] The efficacy and safety of antiangiogenesis tyrosine kinase inhibitors in patients with advanced anaplastic thyroid cancer: A meta-analysis of prospective studies
    Cao, Ru-Bo
    Ge, Yao
    Zhang, Wen-Xuan
    Lin, Guo-He
    Kuang, Bo-Hua
    Wang, Bi-Cheng
    MEDICINE, 2024, 103 (31)
  • [33] Toxicities of tyrosine kinase inhibitors: Occurrence of hemoptysis and tracheo-oesophageal fistula in 150 patients with advanced thyroid cancer.
    Lamartina, Livia
    Ippolito, Serena
    Berdelou, Amandine
    Al Ghuztan, Abir
    Borget, Isabelle
    Leboulleux, Sophie
    Hartl, Dana
    Mirghani, Haitham
    Blanchard, Pierre
    Deandreis, Desiree
    Schlumberger, Martin
    Baudin, Eric
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [34] Neoadjuvant tyrosine kinase inhibitor therapy in locally advanced differentiated thyroid cancer: a single centre case series
    Yeo, J. J. Y.
    Stewart, K.
    Maniam, P.
    Arman, S.
    Srinivasan, D.
    Wall, L.
    MacNeill, M.
    Strachan, M.
    Nixon, I
    JOURNAL OF LARYNGOLOGY AND OTOLOGY, 2023, 137 (11): : 1237 - 1243
  • [35] Endocrine Effects of the Tyrosine Kinase Inhibitor Vandetanib in Patients Treated for Thyroid Cancer
    Brassard, Maryse
    Neraud, Barbara
    Trabado, Severine
    Salenave, Sylvie
    Brailly-Tabard, Sylvie
    Borget, Isabelle
    Baudin, Eric
    Leboulleux, Sophie
    Chanson, Philippe
    Schlumberger, Martin
    Young, Jacques
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (09): : 2741 - 2749
  • [36] Autophagic activation potentiates the antiproliferative effects of tyrosine kinase inhibitors in medullary thyroid cancer DISCUSSION
    Cohen, Mark
    Lin, Chi-Lou
    Phay, John
    Gosnell, Jessica
    SURGERY, 2012, 152 (06) : 1149 - 1149
  • [37] Side effects and medication adherence of tyrosine kinase inhibitors for patients with chronic myeloid leukemia in Taiwan
    Tsai, Yu-Fen
    Huang, Wen-Chuan
    Cho, Shih-Feng
    Hsiao, Hui-Hua
    Liu, Yi-Chang
    Lin, Sheng-Fung
    Liu, Ta-Chih
    Chang, Chao-Sung
    MEDICINE, 2018, 97 (26)
  • [38] FDG-PET for assessment of response to multi-tyrosine kinase inhibitors in patients with iodine-negative thyroid cancer
    Lapa, Constantin
    Hartl, Johannes
    Biko, Johannes
    Zsoter, Norbert
    Papp, Laszlo
    Bundschuh, Ralph
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [39] The patient's perspective on side effects of tyrosine kinase inhibitors in the treatment of advanced and metastatic gastrointestinal stromal tumors
    van de Wal, Deborah
    Venkatesan, Shreenila
    Benson, Charlotte
    van der Graaf, Winette T. A.
    Johnson, Colin D.
    Husson, Olga
    Sodergren, Samantha C.
    FUTURE ONCOLOGY, 2023, 19 (04) : 299 - 314
  • [40] CLINICAL PROFILE, SIDE EFFECTS AND OUTCOME OF NON SMALL CELL LUNG CANCER (NSCLC) TREATED WITH ENDOTHELIAL GROWTH FACTOR RECEPTOR TYROSINE KINASE INHIBITORS (EGFR-TKI) IN MALAYSIAN PATIENTS
    Soosainathan, Patricia Shamani
    Khoon, Ong Choo
    Ching, Lee Wei
    Ali, Irfhan
    RESPIROLOGY, 2015, 20 : 102 - 102
12345